Gemcitabine and oxaliplatinum: an effective regimen in patients with refractory and relapsing Hodgkin lymphoma

BACKGROUND: Most Hodgkin lymphomas (HL) can be cured with current strategies. However, one-third of the cases do not respond or relapse and need salvage regimens. We report the results of a retrospective study using the gemcitabine and oxaliplatinum (GemOx) regimen. METHODS: Patients who relapsed or...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Onco Targets Ther
Main Authors: Gutierrez, Antonio, Rodriguez, Jose, Martinez-Serra, Jordi, Gines, Jordi, Paredes, Pilar, Garcia, Florencia, Vercher, Javier, Balanzat, Josep, del Campo, Raquel, Galan, Pilar, Morey, Miguel, Sampol, Antonia, Novo, Andres, Bento, Leyre, García, Lucia, Bargay, Joan, Besalduch, Joan
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2014
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4235490/
https://ncbi.nlm.nih.gov/pubmed/25419147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S70264
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados